v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
Total
Conversion of convertible notes payable to common stock
Series A Convertible Preferred Stock
Series C Convertible Preferred Stock
Series D Convertible Preferred Stock
Series H Convertible Preferred Stock
Series I Convertible Preferred Stock
Series B Convertible Preferred Stock And Series D Convertible Preferred Stock
Series F Convertible Preferred Stock
Total
Total
Conversion of convertible notes payable to common stock
Total
Series A Convertible Preferred Stock
Total
Series D Convertible Preferred Stock
Total
Series H Convertible Preferred Stock
Total
Series I Convertible Preferred Stock
Total
Series B Convertible Preferred Stock And Series D Convertible Preferred Stock
Total
Series F Convertible Preferred Stock
Preferred Stock
Series A Convertible Preferred Stock
Preferred Stock
Series B Convertible Preferred Stock
Preferred Stock
Series C Convertible Preferred Stock
Preferred Stock
Series D Convertible Preferred Stock
Preferred Stock
Series E Convertible Preferred Stock
Preferred Stock
Series G Convertible Preferred Stock
Preferred Stock
Series H Convertible Preferred Stock
Preferred Stock
Series I Convertible Preferred Stock
Preferred Stock
Series F Convertible Preferred Stock
Common Stock
Common Stock
Conversion of convertible notes payable to common stock
Common Stock
Series C Convertible Preferred Stock
Common Stock
Series H Convertible Preferred Stock
Common Stock
Series B Convertible Preferred Stock And Series D Convertible Preferred Stock
Additional Paid-In Capital
Additional Paid-In Capital
Conversion of convertible notes payable to common stock
Additional Paid-In Capital
Series A Convertible Preferred Stock
Additional Paid-In Capital
Series C Convertible Preferred Stock
Additional Paid-In Capital
Series D Convertible Preferred Stock
Additional Paid-In Capital
Series H Convertible Preferred Stock
Additional Paid-In Capital
Series I Convertible Preferred Stock
Additional Paid-In Capital
Series B Convertible Preferred Stock And Series D Convertible Preferred Stock
Additional Paid-In Capital
Series F Convertible Preferred Stock
Accumulated Deficit
Non- Controlling Interest
Beginning balance (in shares) at Dec. 31, 2024 5,796                                                                                  
Beginning balance at Dec. 31, 2024 $ 1,917,309                                                                                  
Increase (Decrease) in Temporary Equity [Roll Forward]                                                                                    
Common stock redeemed (Mezzanine Equity) (in shares) (3,163)                                                                                  
Common stock redeemed (Mezzanine Equity) $ (1,001,216)                                                                                  
Release of common stock subject to redemption (in shares) (2,633)                                                                                  
Release of common stock subject to redemption $ (916,093)                                                                                  
Ending balance (in shares) at Mar. 31, 2025 0                                                                                  
Ending balance at Mar. 31, 2025 $ 0                                                                                  
Beginning balance (in shares) at Dec. 31, 2024                                   0 3,000 4,851 0 0 0       391,373                              
Beginning balance at Dec. 31, 2024 3,467,758                 $ 3,467,758               $ 0 $ 0 $ 0 $ 0 $ 0 $ 0       $ 38         $ 6,671,081                 $ (3,203,361) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                    
Release of common stock subject to redemption (in shares)                                                     2,654                              
Release of common stock subject to redemption 916,093                 916,093                                           916,093                    
Series A convertible preferred stock in exchange of Series A Convertible Preferred Stock categorized as liability (in shares)                                   106,816                                                
Series A convertible preferred stock in exchange of Series A Convertible Preferred Stock categorized as liability     $ 1,391,176                 $ 1,391,176           $ 11                               $ 1,391,165                
Series D convertible preferred stock in exchange of convertible notes (in shares)                                         6,666,666                                          
Convertible preferred stock in exchange of convertible notes         $ 3,333,335               $ 3,333,335               $ 667                             $ 3,332,668            
Common stock issued for conversion of preferred stock and conversion of convertible notes payable (in shares)                                     (2,999)   (6,516,666)                   420,515                      
Common stock issued for conversion of preferred stock and conversion of convertible notes payable               $ 0               $ 0         $ (652)                   $ 42               $ 610      
Common stock issued for exercise of warrants (in shares)                                                     236,709                              
Common stock issued for exercise of warrants 3,309,921                 3,309,921                                 $ 24         3,309,897                    
Preferred stock as part of Secuvant acquisition and common stock issued for business combination costs (in shares)                                                     25,200                              
Preferred stock as part of Secuvant acquisition and common stock issued for business combination costs 9,000,000                 9,000,000                                 $ 3         8,999,997                    
Common stock issued for settlement of liability (in shares)                                                     2,648                              
Common stock issued for settlement of liability 945,636                 945,636                                           945,636                    
Common stock issued for employment agreement (in shares)                                                     16,800                              
Common stock issued for employment agreement 250,000                 250,000                                 $ 2         249,998                    
SLG transaction (in shares)                                           51         17,074                              
SLG transaction 509,071                 509,071                                 $ 2         509,069                    
Excise tax liability arising from redemption of Series A shares (3,474,230)                 (10,012)                                                             (10,012) (3,464,218)
Net loss (10,248,486)                 (10,248,486)                                                             (10,248,486)  
Ending balance (in shares) at Mar. 31, 2025                                   106,816 1 4,851 150,000 51       0 1,112,973                              
Ending balance at Mar. 31, 2025 $ 9,400,274                 12,864,492               $ 11 $ 0 $ 0 $ 15 $ 0       $ 0 $ 111         26,326,214                 (13,461,859) (3,464,218)
Beginning balance (in shares) at Dec. 31, 2024 5,796                                                                                  
Beginning balance at Dec. 31, 2024 $ 1,917,309                                                                                  
Ending balance (in shares) at Jun. 30, 2025 0                                                                                  
Ending balance at Jun. 30, 2025 $ 0                                                                                  
Beginning balance (in shares) at Dec. 31, 2024                                   0 3,000 4,851 0 0 0       391,373                              
Beginning balance at Dec. 31, 2024 3,467,758                 3,467,758               $ 0 $ 0 $ 0 $ 0 $ 0 $ 0       $ 38         6,671,081                 (3,203,361) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                    
Net loss (15,538,900)                                                                                  
Ending balance (in shares) at Jun. 30, 2025                                   106,816 1 4,851 150,000 51       3,318 1,391,356                              
Ending balance at Jun. 30, 2025 $ 10,448,853                 14,014,730               $ 11 $ 0 $ 0 $ 15 $ 0       $ 0 $ 139         32,665,179                 (18,650,614) (3,565,877)
Beginning balance (in shares) at Dec. 31, 2024 5,796                                                                                  
Beginning balance at Dec. 31, 2024 $ 1,917,309                                                                                  
Beginning balance (in shares) at Dec. 31, 2024                                   0 3,000 4,851 0 0 0       391,373                              
Beginning balance at Dec. 31, 2024 3,467,758                 3,467,758               $ 0 $ 0 $ 0 $ 0 $ 0 $ 0       $ 38         6,671,081                 (3,203,361) 0
Ending balance (in shares) at Dec. 31, 2025                                     1 4,851 150,000 51 143 0 0   3,642,501                              
Ending balance at Dec. 31, 2025 $ 16,243,466                 20,101,060                 $ 0 $ 0 $ 15 $ 0 $ 0 $ 0 $ 0   $ 364         46,979,762                 (26,879,081) (3,857,594)
Beginning balance (in shares) at Mar. 31, 2025 0                                                                                  
Beginning balance at Mar. 31, 2025 $ 0                                                                                  
Ending balance (in shares) at Jun. 30, 2025 0                                                                                  
Ending balance at Jun. 30, 2025 $ 0                                                                                  
Beginning balance (in shares) at Mar. 31, 2025                                   106,816 1 4,851 150,000 51       0 1,112,973                              
Beginning balance at Mar. 31, 2025 9,400,274                 12,864,492               $ 11 $ 0 $ 0 $ 15 $ 0       $ 0 $ 111         26,326,214                 (13,461,859) (3,464,218)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                    
Series D convertible preferred stock in exchange of convertible notes (in shares)                                                   3,318                                
Convertible preferred stock in exchange of convertible notes                 $ 4,183,891               $ 4,183,891                                             $ 4,183,891    
Common stock issued for exercise of warrants (in shares)                                                     107,823                              
Common stock issued for exercise of warrants 354,750                 354,750                                 $ 11         354,739                    
Common stock issued for settlement of liability (in shares)                                                     92,152                              
Common stock issued for settlement of liability 1,028,478                 1,028,478                                 $ 9         1,028,469                    
Common stock issued for employment agreement (in shares)                                                     22,964                              
Common stock issued for employment agreement 256,299                 256,299                                 $ 2         256,297                    
Common stock issued - equity line (in shares)                                                     38,640                              
Common stock issued - equity line 265,504                 265,504                                 $ 4         265,500                    
SLG transaction (in shares)                                                     16,804                              
SLG transaction 250,071                 250,071                                 $ 2         250,069                    
Net loss (5,290,414)                 (5,188,755)                                                             (5,188,755) (101,659)
Ending balance (in shares) at Jun. 30, 2025                                   106,816 1 4,851 150,000 51       3,318 1,391,356                              
Ending balance at Jun. 30, 2025 10,448,853                 14,014,730               $ 11 $ 0 $ 0 $ 15 $ 0       $ 0 $ 139         32,665,179                 (18,650,614) (3,565,877)
Beginning balance (in shares) at Dec. 31, 2025                                     1 4,851 150,000 51 143 0 0   3,642,501                              
Beginning balance at Dec. 31, 2025 16,243,466                 20,101,060                 $ 0 $ 0 $ 15 $ 0 $ 0 $ 0 $ 0   $ 364         46,979,762                 (26,879,081) (3,857,594)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                    
Common stock issued for conversion of preferred stock and conversion of convertible notes payable (in shares)                                       (2,304)                 196,801                          
Common stock issued for conversion of preferred stock and conversion of convertible notes payable       $ 0                                                 $ 20           $ (20)              
Common stock issued for exercise of warrants (in shares)                                                     1,670,719                              
Common stock issued for exercise of warrants 167                 167                                 $ 167                              
Net loss (2,561,786)                 (2,128,462)                                                             (2,128,462) (433,324)
Ending balance (in shares) at Mar. 31, 2026                                     1 2,547 150,000 51 143 0 0   5,510,021                              
Ending balance at Mar. 31, 2026 13,681,847                 17,972,765                 $ 0 $ 0 $ 15 $ 0 $ 0 $ 0 $ 0   $ 551         46,979,742                 (29,007,543) (4,290,918)
Beginning balance (in shares) at Dec. 31, 2025                                     1 4,851 150,000 51 143 0 0   3,642,501                              
Beginning balance at Dec. 31, 2025 16,243,466                 20,101,060                 $ 0 $ 0 $ 15 $ 0 $ 0 $ 0 $ 0   $ 364         46,979,762                 (26,879,081) (3,857,594)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                    
Net loss (6,601,353)                                                                                  
Ending balance (in shares) at Jun. 30, 2026                                     1 2,547 150,000 51 143 1,900 888,888   11,889,767                              
Ending balance at Jun. 30, 2026 18,208,398                 22,783,109                 $ 0 $ 0 $ 15 $ 0 $ 0 $ 0 $ 89   $ 1,189         55,545,133                 (32,763,317) (4,574,711)
Beginning balance (in shares) at Mar. 31, 2026                                     1 2,547 150,000 51 143 0 0   5,510,021                              
Beginning balance at Mar. 31, 2026 13,681,847                 17,972,765                 $ 0 $ 0 $ 15 $ 0 $ 0 $ 0 $ 0   $ 551         46,979,742                 (29,007,543) (4,290,918)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                    
Series D convertible preferred stock in exchange of convertible notes (in shares)                                               1,900                                    
Convertible preferred stock in exchange of convertible notes           $ 1,899,945               $ 1,899,945                                             $ 1,899,945          
Common stock issued for conversion of preferred stock and conversion of convertible notes payable (in shares)                                                       531,822   101,552                        
Common stock issued for conversion of preferred stock and conversion of convertible notes payable   $ 443,398       $ 0         $ 443,398                                 $ 53   $ 10     $ 443,345       $ (10)          
Preferred stock as part of Secuvant acquisition and common stock issued for business combination costs (in shares)                                                 888,888                                  
Preferred stock as part of Secuvant acquisition and common stock issued for business combination costs             $ 2,000,000               $ 2,000,000                   $ 89                         $ 1,999,911        
Common stock issued for settlement of liability (in shares)                                                     495,645                              
Common stock issued for settlement of liability 466,941                 466,941                                 $ 50         466,891                    
Common stock issued for employment agreement (in shares)                                                     320,727                              
Common stock issued for employment agreement 334,638                 334,638                                 $ 32         334,606                    
Common stock issued - equity line (in shares)                                                     4,930,000                              
Common stock issued - equity line 3,421,196                 3,421,196                                 $ 493         3,420,703                    
Net loss (4,039,567)                 (3,755,774)                                                             (3,755,774) (283,793)
Ending balance (in shares) at Jun. 30, 2026                                     1 2,547 150,000 51 143 1,900 888,888   11,889,767                              
Ending balance at Jun. 30, 2026 $ 18,208,398                 $ 22,783,109                 $ 0 $ 0 $ 15 $ 0 $ 0 $ 0 $ 89   $ 1,189         $ 55,545,133                 $ (32,763,317) $ (4,574,711)